Targeting mTOR/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation-Reference-Cited by-同舟云学术

Targeting mTOR/YY1 signaling pathway by quercetin through CYP7A1-mediated cholesterol-to-bile acids conversion alleviated type 2 diabetes mellitus induced hepatic lipid accumulation

Published:2023-05 Issue: Volume:113 Page:154703
ISSN:0944-7113
Container-title:Phytomedicine
language:en
Short-container-title:Phytomedicine

Author:

Yang Tingting^ORCID,Wang Yiying,Cao Xinyun,Peng Yuting,Huang Jiawan,Chen Li,Pang Jiale,Jiang Zhenzhou,Qian Sitong,Liu Ying,Ying Changjiang,Wang Tao,Zhang Fan,Lu Qian,Yin Xiaoxing

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine

Reference82 articles.

1. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus;Akash;J. Cell. Biochem.,2018

2. Flavonoids and their anti-diabetic effects: cellular mechanisms and effects to improve blood sugar levels;Al-Ishaq;Biomolecules,2019

3. Hepatocellular carcinoma development in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Is it going to be the "Plague" of the 21st century? A literature review focusing on pathogenesis, prevention and treatment;Argyrou;J Buon,2017

4. Yin-Yang 1 transcription factor modulates ST2 expression during adverse cardiac remodeling post-myocardial infarction;Asensio-Lopez;J. Mol. Cell. Cardiol.,2019

5. Antidiabetic potential of flavonoids from traditional chinese medicine: a review;Bai;Am. J. Chin. Med.,2019

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Jujuboside A through YY1/CYP2E1 signaling alleviated type 2 diabetes-associated fatty liver disease by ameliorating hepatic lipid accumulation, inflammation, and oxidative stress;Chemico-Biological Interactions;2024-09

2. Quercetin represses cholesterol metabolism and mitigates resistance to cisplatin in oral squamous cell carcinoma by regulating AGR2/AKT/SREBP2 axis;Heliyon;2024-09

3. Role of HSP90 in Type 2 Diabetes Mellitus and Its Association with Liver Diseases;Molecular Biotechnology;2024-08-20

4. Unlocking Cholesterol Metabolism in Metabolic-Associated Steatotic Liver Disease: Molecular Targets and Natural Product Interventions;Pharmaceuticals;2024-08-15

5. Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies;Chinese Journal of Natural Medicines;2024-08